The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943 · cited 1×
“…(constructed by inserting fragments carrying the CMV promoter and rtTA gene (tetRrVP16 fusion) from pUHD172-1neo (Gossen et al., 1995) and the PhCMV*-1 regulatory promoter from pUHG 10-3 (Gossen and Bujard, 1992) into pcDNA3) to create pCAMTet GFP-Peptide3. pRGCDfoslacZ was a gift from SH Friend.”
MethodMdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 1×
“Honda et al. (1997) have demonstrated that Mdm2 may act as a ubiquitin ligase which binds p53 and targets it to the proteasome and transfection of plasmids expressing Mdm2 into human cells accelerates p53 degradation (Haupt et al., 1997; Kubbutat et al., 1997; Midgley and Lane, 1997).”
BackgroundMomand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
Transcriptional Activation by Tetracyclines in Mammalian Cells
Gossen, M., Freundlieb, S., Bender, G., Müller, G., Hillen, W., & Bujard, H. (1995) · Science · doi:10.1126/science.7792603 · Cited by 2,488 · cited 1×
“…expression vector pCAMTet (constructed by inserting fragments carrying the CMV promoter and rtTA gene (tetRrVP16 fusion) from pUHD172-1neo (Gossen et al., 1995) and the PhCMV*-1 regulatory promoter from pUHG 10-3 (Gossen and Bujard, 1992) into pcDNA3) to create pCAMTet GFP-Peptide3.…”
DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
Honda, R., Tanaka, H., & Yasuda, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01480-4 · Cited by 1,951
Amplification of a gene encoding a p53-associated protein in human sarcomas
Oliner, J. D., Kinzler, K. W., Meltzer, P. S., George, D. L., & Vogelstein, B. (1992) · Nature · doi:10.1038/358080a0 · Cited by 1,949
Zhang, Y., Xiong, Y., & Yarbrough, W. G. (1998) · Cell · doi:10.1016/s0092-8674(00)81401-4 · Cited by 1,626
Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
Research works printed but not linked: 42
- Barak Y, Juven T, Haffner R and Oren M . 1993 EMBO J 12: 461–468 · DOI · Paper page
- Blattner C, Sparks A and Lane D . 1999 Mol Cell Biol 19: 3704–3713 · DOI · Paper page
- Blaydes JP, Gire V, Rowson JM and Wynford-Thomas D . 1997 Oncogene 14: 1859–1868 · DOI
- Chen J, Marechal V and Levine AJ . 1993 Mol Cell Biol 13: 4107–4114 · DOI · Paper page
- Ciechanover A, Heller H, Elias S, Haas AL and Hershko A . 1980 Proc Natl Acad Sci USA 77: 1365–1368 · DOI · Paper page
- de Stanchina E, McCurrach ME, Zindy F, Shieh S-Y, Ferbeyre G, Samuelson AV, Prives C, Roussel MF, Sherr CJ and Lowe SW . 1998 Genes Dev 12: 1434–1442 · DOI · Paper page
- Desterro JM, Thomson J and Hay RT . 1997 FEBS Lett 417: 297–300 · DOI · Paper page
- Desterro JM, Rodrigues MS, Kemp GD and Hay RT . 1999 J Biol Chem 274: 10618–10624 · DOI · Paper page
- Florenes VA, Maelandsmo GM, Forus A, Andreassen A, Myklebost O and Forstad O . 1994 J Natl Cancer Inst 86: 1297–1302 · DOI · Paper page
- Freedman DA and Levine AJ . 1998 Mol Cell Biol 18: 7288–7293 · DOI · Paper page
- Giaccia AJ and Kastan MB . 1998 Genes Dev 12: 2973–2983 · DOI · Paper page
- Gu W and Roeder RG . 1997 Cell 90: 595–606 · DOI · Paper page
- Haas AL, Warms JV Hershko A and Rose IA . 1982 J Biol Chem 27: 2543–2548 · DOI · Paper page
- Hansen S, Hupp TR and Lane DP . 1996 J Biol Chem 271: 3917–3924 · DOI
- Hansen S, Lane DP and Midgley CA . 1998 J Mol Biol 275: 575–588 · DOI
- Hershko A and Ciechanover A . 1998 Ann Rev Biochem 67: 425–479 · DOI · Paper page
- Hsieh J-K, Chan FSG, O'Connor DJ, Mittnacht S, Zhong S and Lu X . 1999 Mol Cell 3: 181–193 · DOI · Paper page
- Hupp TR and Lane DP . 1994 Curr Biol 4: 865–875 · DOI · Paper page
- Hupp TR, Sparks A and Lane DP . 1995 Cell 83: 237–245 · DOI · Paper page
- Ko, LJ and Prives C . 1996 Genes Dev 10: 1054–1072 · DOI · Paper page
- Korsus E, Torchia J, Ros DW, Xu L, Kurokawa R, McInerney EM, Mullen TM, Glass CK and Rosenfeld MG . 1998 Science 279: 703–707 · DOI · Paper page
- Lain S, Midgley C, Sparks A Lane EB and Lane DP . 1999 Exp Cell Res 248: 457–472 · DOI
- Levine AJ . 1997 Cell 88: 323–331 · DOI · Paper page
- Liu HS, Jan MS, Chou CK, Chen PH, Ke NJ . 1999 Biochem Biophys Res Comm 260: 712–717 · DOI · Paper page
- Maki CG and Howley PM . 1997 Mol Cell Biol 17: 355–363 · DOI · Paper page
- Midgley CA, Fisher CJ, Bartek J, Vojtesek B, Lane D and Barnes DM . 1992 J Cell Sci 101: 183–189 · DOI · Paper page
- Midgley CA and Lane DP . 1997 Oncogene 15: 1179–1189 · DOI · Paper page
- Oliner JD, Pietenpol JA, Thiagalingam S, Gyuris J, Kinzler KW and Vogelstein B . 1993 Nature 362: 857–860 · DOI · Paper page
- Quelle DE, Zindy F, Ashmun RA, and Scherr CJ . 1995 Cell 83: 993–1000 · DOI · Paper page
- Quelle DE, Cheng M, Ashmun RA and Sherr CJ . 1997 Proc Natl Acad Sci USA 94: 669–673 · DOI · Paper page
- Roth J, Dobbelstein M, Freedman DA, Shenk T and Levine AJ . 1998 EMBO J 17: 554–564 · DOI · Paper page
- Ruas M and Peters G . 1998 Biochem Biophys Acta 1378: F115–F177 · DOI · Paper page
- Sambrook J, Fritsch EF and Maniatis T . 1989 Molecular Cloning A Laboratory Manual Cold Spring Harbor Laboratory Press New York
- Scheffner M, Huibregtse JM, Vierstra RD and Howley RD . 1993 Cell 75: 495–505 · DOI · Paper page
- Stott FJ, Bates S, James MC, McConnell BB, Starborg M, Brookes S, Palmero I, Ryan K, Hara E, Vousden K and Peters G . 1998 EMBO J 17: 5001–5014 · DOI · Paper page
- Tao W and Levine AJ . 1999 Proc Natl Acad Sci 96: 6937–6941 · DOI · Paper page
- Vojtesek B and Lane DP . 1993 J Cell Sci 105: 607–612 · DOI
- Weber JD, Taylor LJ, Roussel MF, Sherr CJ and BarSagi D . 1999 Nature Cell Biol 1: 20–26 · DOI · Paper page
- Wu L and Levine AJ . 1997 Mol Med 3: 441–451 · doi:10.1016/s0030-6665(20)30222-x
- Wu X, Bayle JH, Olsen D and Levine AJ . 1993 Genes Dev 7: 1126–1132 · DOI · Paper page
- Zhang Y and Xiong Y . 1999 Molec Cell 3: 579–591 · DOI · Paper page
- zur Hausen H and Schneider A . 1987 In The Papovaviridae, vol 2 Papillomaviruses PM Howley and NP Salzman eds Plenum Press New York pp 245–263 · DOI · Paper page
Cited by
Showing your ID: intrinsic disorder as an ID for recognition, regulation and cell signaling
Uversky, V. N., Oldfield, C. J., & Dunker, A. K. (2005) · Journal of Molecular Recognition · doi:10.1002/jmr.747 · Cited by 847
Mono- Versus Polyubiquitination: Differential Control of p53 Fate by Mdm2
Li, M., Brooks, C. L., Wu-Baer, F., Chen, D., Baer, R., & Gu, W. (2003) · Science · doi:10.1126/science.1091362 · Cited by 804
ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage
Maya, R., Balass, M., Kim, S.-T., Shkedy, D., Leal, J.-F. M., Shifman, O., Moas, M., Buschmann, T., Ronai, Z., Shiloh, Y., et al. (2001) · Genes & Development · doi:10.1101/gad.886901 · Cited by 731
“Similar observations were reported recently by Lane and coworkers (Midgley et al. 2000).”
ResultChowdhry, S., Zhang, Y., McMahon, M., Sutherland, C., Cuadrado, A., & Hayes, J. D. (2013) · Oncogene · doi:10.1038/onc.2012.388 · Cited by 657
Regulation of HDM2 activity by the ribosomal protein L11
Lohrum, M. A. E., Ludwig, R. L., Kubbutat, M. H. G., Hanlon, M., & Vousden, K. H. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00134-x · Cited by 623
Metadata
- Authors
- Midgley, C. A., Desterro, J. M., Saville, M. K., Howard, S., Sparks, A., Hay, R. T., & Lane, D. P.
- Venue
- Oncogene
- Published
- 2000-05-04
- Volume
- 19
- Issue
- 19
- Pages
- 2312-2323
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2004706142
- Cited by
- 252
- References
- 20
- FWCI
- 10.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo. https://app.cochat.ai/papers/10.1038/sj.onc.1203593
- The paper
- Midgley, C. A., Desterro, J. M., Saville, M. K., Howard, S., Sparks, A., Hay, R. T., & Lane, D. P. (2000). An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo. Oncogene. https://doi.org/10.1038/sj.onc.1203593
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
